Uncategorized

Erasca reports RAS cancer drug data after legal threat from Revolution

Erasca reports RAS cancer drug data after legal threat from Revolution

Published

1 week ago

on

After a new drug from Revolution Medicines reignited hopes for treating pancreatic cancer, a rival compound from Erasca — which released early-stage data on Monday — could prompt a legal showdown between the biotechs.

And it did …​ ​Read More

Related Topics:

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version